Julier Medical AG
USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Julier ranks #48,027 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 1 technology areas.
- #48,027
- of 49,997 US assignees by volume
- Top 25%
- by Innovation Score (44.5/100)
- 24.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R48027 · Foreign Corporation #48,027 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,027/49,997
- PHOTO-FINISH Jowat
- CPC-NARROW A61B · 1 areas
- INNOV-PAR 44.5/100
- CLAIMS-DENSE 24.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2023–2024 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Jowat AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Julier’s 44.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Julier
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Julier Medical · this assignee
Julier Medical · this assignee
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Julier's Innovation Score is 44.5/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Julier?
Each dot is one of Julier’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Julier’s own 24.6 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Julier's grants concentrate
Julier Medical AG is a focused PatentsView assignee: 1 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (3 grants) versus a trough of 2 in 2024. By volume, Julier sits between Jowat AG and Jupiter Oxygen Corporation.
Julier's three-year grant acceleration
Julier Medical AG shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Julier's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Jowat
Jowat AG
5 patents
- Jowat SE
Jowat SE
5 patents
- Joytunes
Joytunes Ltd.
5 patents
- Jubilant Life Sci…
Jubilant Life Sciences Limited
5 patents
- Julius Montz
Julius Montz GmbH
5 patents
- Julius Zorn
Julius Zorn Inc.
5 patents
- Junttan Oy
Junttan Oy
5 patents
- Jupiter Oxygen
Jupiter Oxygen Corporation
5 patents
- Julier Medical ◀
Julier Medical AG
5 patents
What this shows Julier holds 5 patents at rank #48,038, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Julier
By rank, the assignees closest to #48,038 in granted patent volume.
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Julier's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Julier's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 3 | 60.0% |
| 2024 | 2 | 40.0% |
Which technologies does Julier Medical AG patent most?
Top 1 of 1 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Julier Medical AG's patent record in context - here's where to go next.
- Julier Medical AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #48,027 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Julier Medical AG against Jowat AG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.